MADRE (Mammograms Available Due to Research and Education)

Launched by UNIVERSITY OF ILLINOIS AT CHICAGO · Apr 23, 2023

Keywords

ClinConnect Summary

This clinical trial, titled "Empowering Latinas to Obtain Guideline Concordant Screenings," is focused on improving breast cancer screening among Latina women. The researchers want to see how different support methods can help women get the screenings they need, especially those who haven't followed current guidelines for breast cancer screening. The study will track how well these methods work over time, comparing initial and follow-up screenings.

To participate, women need to be between 50 and 74 years old, identify as Latina, and have not had a mammogram in the past two years. There are two groups in the study: the first group is for women who haven't followed screening guidelines, while the second group includes women who are eligible for screenings but were referred by someone in the first group. Participants can expect to receive support and resources to help them get screened for breast cancer. This study is currently recruiting participants, so if you or someone you know fits the criteria, it's a great opportunity to help improve health outcomes for Latina women in the community.

Gender

FEMALE

Eligibility criteria

• • Aim 1
• Inclusion Criteria:
• • female biological sex
• • identification as Latinas
• • non-adherence to USPSTF guidelines (42-74 years old, no mammogram in past 2 years, no previous BC diagnosis)
• • no previous history of health volunteerism
• • not a network member enrolled in Aim 2.
• • Exclusion Criteria
• • \* Not meeting at least one of the aforementioned Aim 1 inclusion criteria.
• • Aim 2.
• Inclusion Criteria:
• • female biological sex
• • eligibility to obtain BC screenings by USPSTF guidelines (i.e., 40-74 years old, no personal BC history)
• • referral from Aim 1 participants
• • no previous history of health volunteerism
• • no participation in the RCT (not an Aim 1 participant, no Session #3 attendance).
• Exclusion Criteria:
• • Not meeting at least one of the aforementioned Aim 1 inclusion criteria.